ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Natural Antibodies and Left Ventricular Assist Device Complications

S. B. See1, D. Onat2, E. Hittesdorf3, F. McDougan4, M. Yuzefpolskaya2, V. K. Topkara2, Y. Naka5, H. Takayama5, K. Takeda5, G. Milligan6, D. Wencker6, S. Hall6, M. Askar6, P. Kimball4, G. Wagener3, P. C. Colombo2, E. Zorn1

1Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, 2Department of Medicine, Columbia University Irving Medical Center, New York, NY, 3Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY, 4Department of Transplant Surgery, Virginia Commonwealth University, Richmond, VA, 5Department of Surgery, Columbia University Irving Medical Center, New York, NY, 6Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX

Meeting: 2020 American Transplant Congress

Abstract number: D-330

Keywords: Antibodies, Autoimmunity, Ventricular assist devices

Session Information

Session Name: Poster Session D: B-cell / Antibody /Autoimmunity

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Left ventricular assist device (LVAD) implantation is followed by a sharp increase in serum levels of IgG natural antibodies (Nabs) recognizing oxidation-specific epitopes (OSE) and apoptotic cells. The consequence of IgG Nabs production following LVAD is not known. We hypothesized that Nabs following implant may be associated with LVAD complications, promoting thrombosis, stroke or bleeding.

*Methods: We studied a multicenter cohort (n=71) of adults who received a continuous flow LVAD at three university hospitals in the United States. Nabs were measured in longitudinal sera by assessing IgG reactivity to the OSE malondialdehyde (MDA) and to apoptotic Jurkat cells. Wilcoxon’s signed rank test for matched pairs was used to compare measurements.

*Results: Mean IgG Nabs levels were significantly increased in post-LVAD sera at 1 (0.41±0.05 Nabs units, p<0.0001), 6 (0.63±0.074, p<0.0001) and 12 months (0.49±0.69, p=0.0004) compared to pre-LVAD (0.19±0.021). Kinetics of Nabs development was found to differ between centers with 90.9% of center 1 patients developing elevated Nabs at 6 months post-implantation compared to 30% and 29.7% for center 2 and center 3, respectively. Preliminary analysis revealed elevated Nabs in 2/3 center 3 patients with pump thrombosis and 1/2 with stroke within the first year post-LVAD.

*Conclusions: Our studies revealed that serum IgG Nabs are elevated following LVAD implant. The appearance of Nabs differed between the centers. We are investigating the possible contribution of differing perioperative procedures on Nabs development. Preliminary findings suggest that IgG Nabs may be associated with thromboembolism. Analysis of adverse events in the other centers are forthcoming.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

See SB, Onat D, Hittesdorf E, McDougan F, Yuzefpolskaya M, Topkara VK, Naka Y, Takayama H, Takeda K, Milligan G, Wencker D, Hall S, Askar M, Kimball P, Wagener G, Colombo PC, Zorn E. Natural Antibodies and Left Ventricular Assist Device Complications [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/natural-antibodies-and-left-ventricular-assist-device-complications-2/. Accessed May 28, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences